Compare AdaptHealth Corp (AHCO) vs iShares China Large-Cap ETF (FXI) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AdaptHealth Corp vs iShares China Large-Cap ETF — how do they compare? AdaptHealth Corp trades at $10.03 (market cap $1.38B), while iShares China Large-Cap ETF trades at $33.5. Which is the better fit depends on your goals.
| AHCO | FXI | |
|---|---|---|
Market Cap | $1.38B | — |
Sector | Health | — |
52-Week High | $13.38 | $41.75 |
52-Week Low | $8.68 | $31.59 |
Enterprise Value | $3.33B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.
The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.
The iShares China Large-Cap ETF (FXI) trades at $32.51, up 1.88% on the day, while technical indicators signal a bearish trend with moving averages and overall momentum favoring sellers. Recent news highlights China's AI and chip sector driving factory rebounds and IPO activity, though broader sentiment on Chinese equities remains mixed, with some analysts labeling them as potential value traps. The ETF shows neutral oscillator readings with key support at $32 and resistance at $33.
The outlook for FXI is clouded by structural macroeconomic headwinds in China, including deflationary pressures and geopolitical tensions with the U.S., which offset potential opportunities from the country's massive AI infrastructure investment plans. While the sector benefits from technology self-reliance initiatives, persistent risks to corporate profitability and valuation compression suggest a cautious approach for equity investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AdaptHealth Corp
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →About iShares China Large-Cap ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index designed to measure the performance of the largest companies in the Chinese equity market that trade on the Stock Exchange of Hong Kong and are available to international investors. The fund is non-diversified.
Read more on FXI →
